news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

As the new week begins, let’s take a brief look back at the investment and financing transactions disclosed last week.

Among the newly disclosed financing in the consumer service sector, one financing was completed in the agricultural sector. Boridi completed a RMB 250 million Series B financing, led by Yimiba Agricultural Technology Group.

Among the newly disclosed financings in the pharmaceutical and health sector, three financings were completed in the medical device track. Juhai Hengchuang completed an angel round of financing of 30 million yuan, led by Hangzhou Taiyu Investment; Ruipai Medical completed a D round of financing of several hundred million yuan, led by Tianxin Emerging Industry Fund under CICC Capital; and Microlon completed a Pre-A round of financing of tens of millions of yuan, jointly invested by Chengdu Science and Technology Innovation Investment Group Co., Ltd. and Sichuan Development Industry Guidance Equity Investment Fund Management Co., Ltd.

Among the newly disclosed financings in the technology and manufacturing sectors, multiple financings were completed in the fields of artificial intelligence and advanced manufacturing. LiblibAI completed a round A financing of several hundred million yuan, led by Mingshi Capital; Deep Blue Aerospace completed a round B2 financing of several hundred million yuan, led by Wuxi High-tech Zone Investment and Control Group

According to incomplete statistics from 21 Ventures, there were 22 financing events in the domestic primary market from July 29 to August 4 during the reporting period. Among them, 18 financing events disclosed the financing amount and currency information, with a total scale of over hundreds of millions.

01. Multiple financings completed in the field of technology manufacturing

This week, the artificial intelligence and advanced manufacturing sub-tracks completed 6 financings, with financing amounts of hundreds of millions of yuan, far ahead of other tracks. In addition, enterprise services and production manufacturing each completed 1 financing this week.

02. Guangdong Province, Jiangsu Province and Shanghai completed multiple financings

Judging from the geographical distribution of disclosed investment-receiving enterprises, this week's financing regions were mainly concentrated in Guangdong Province, Jiangsu Province, and Shanghai, which completed 9, 3, and 3 financings respectively.

03. Which investment institutions are more active?

In terms of institutional investment activity, Shangxin Capital was relatively active this week, completing two financings, mainly in the fields of medical services and innovative drugs.

The following is a summary of investment and financing information: Consumer Services

Boredi completes RMB 250 million Series B financing, led by Yimiba Agricultural Technology Group

On July 30, Shijiazhuang Boredi Biotechnology Co., Ltd. (hereinafter referred to as "Boredi") announced the completion of its B round of financing, with a total amount of 250 million yuan. This round of financing was led by Yimiba Agricultural Technology Group, followed by Qingchi Capital, Su Venture Capital, Guofa Venture Capital, and other investors. Old shareholders Daotong Investment and Haochen Capital continued to increase their investment. Kaicheng Capital served as the exclusive financial advisor for this round of financing. The lead investor is an agricultural brand founded by former Ant Group CEO Hu Xiaoming. This round of financing will mainly be used for biological breeding technology and platform research and development, overseas business expansion, etc.

Founded in 2017, Boridi is a national high-tech enterprise focusing on the research and development of biobreeding technology and services. It is committed to promoting the transformation from "experience-based breeding" to "precision breeding" and "intelligent breeding".

medical health

Juhai Hengchuang completed 30 million yuan angel round financing, led by Hangzhou Taiyu Investment

On July 30, Hangzhou Juhai Hengchuang announced that it had completed an angel round of financing of 30 million yuan. This round of financing was led by Hangzhou Taiyu Investment and followed by Deshi Capital. The funds will be mainly used for R&D investment, market expansion, etc.

Juhai Hengchuang was established in 2017. It is a Beijing high-tech enterprise and a Zhongguancun high-tech enterprise. It is mainly responsible for the design and manufacturing of equipment products. At present, its flagship products include nucleic acid synthesis equipment, aminolysis and elution equipment, workstations of different specifications and other core equipment products. The integrated fully automatic production line occupies an important position in the nucleic acid synthesis industry.

Zean Biopharmaceuticals Completes Series A Financing, Led by Longpan Investment

On July 30, Shenzhen, China and Redwood City, California, USA - LTZ Therapeutics ("LTZ") announced the completion of its Series A financing, raising more than US$20 million. This round of financing was led by Longpan Investment, with participation from Hillhouse Capital, and additional investment from old shareholders such as Qiming Venture Partners, Xiangfeng Qiyun, and Shunwei Capital.

Founded in 2002, Zean Biopharma has raised approximately US$50 million since its inception in 2022. This round of new funds will be mainly used to accelerate the development of the LTZ pipeline, including applying for clinical trial approval (IND), launching Phase I clinical studies of the first variety LTZ-301 and IND-enabling work of the second variety LTZ-232, and rapidly advancing other research projects; in addition, it will also be used to further expand the global team.

Ruipai Medical completed a round D financing of hundreds of millions of yuan, led by Tianxin Emerging Industry Fund under CICC Capital

On July 30, Guangzhou Ruipai Medical Devices Co., Ltd. (hereinafter referred to as "Ruipai Medical"), a global disposable endoscope company, announced the successful completion of a round D financing of several hundred million yuan. This round of financing was led by Tianxin Emerging Industry Fund under CICC Capital, followed by Guangzhou Industrial Investment, Suzhou Yihe, Qingke Capital, and Tongying Venture Capital, and old shareholders Yuexiu Industrial Fund and Yuanhe Yuandian continued to increase their investment.

Ruipai Medical was founded in 2015. After this round of financing, Ruipai Medical will continue to promote the construction of intelligent endoscopic operating rooms and provide disposable endoscopic diagnosis and treatment solutions covering all departments for medical institutions, doctors and patients.

Micron completes tens of millions of yuan in Pre-A round of financing

On July 30, Sichuan Microlon Biotechnology Co., Ltd. (hereinafter referred to as "Microlon"), an innovative high-tech enterprise focusing on microfluidic intelligent manufacturing technology, has successfully completed a Pre-A round of financing of tens of millions of yuan. This round was jointly invested by Chengdu Science and Technology Innovation Investment Group Co., Ltd. and Sichuan Development Industry Guidance Equity Investment Fund Management Co., Ltd.

Founded in 2022, Microfluidics is a leader in the microfluidic controllable preparation of functional microspheres. It has established a number of cutting-edge theories for the preparation of functional microspheres using microfluidic technology, innovated new strategies for fluid manipulation in confined spaces, and built new methods for chip development and design. Microfluidics pioneered the use of closed and open amplification systems to create a microsphere mass production system, successfully achieving the controllable preparation of hundreds of functional microspheres.

Zhikang Hongyi completed a multi-billion-yuan A+ round of financing, led by Xi Venture Capital and Binhu Industrial Group

On August 1, Zhikang Hongyi announced that it had successfully completed a multi-billion-yuan A+ round of financing. This round of financing was led by Xi Venture Capital and Binhu Industry Group, and the company's original shareholders such as WuXi Biologics continued to invest.

Zhikang Hongyi was founded in 2017. As an innovation-driven biotechnology company, Xi Venture Capital attaches great importance to its dual-wheel drive concept of "science + business". It takes disease biology and translational medicine research as its core competitiveness and is committed to conducting research on new targets and new mechanisms in the target field.

Shenji Changhua completed nearly 100 million yuan in Pre-A round of financing, led by Zhongguancun Capital

On August 1, Shenji Changhua (Beijing) Biotechnology Co., Ltd. completed a Pre-A round of financing of nearly 100 million yuan, led by Zhongguancun Capital, followed by Zhongbo Juli, Chuanhua Capital and Sanmei Investment. The funds raised in this round will be mainly used for the IND application of Shenji Changhua's first pipeline SNUG01 and the promotion of other pipeline products.

Shenji Changhua was founded in 2021. Relying on more than ten years of scientific research accumulation of Professor Jia Yichang's team from the School of Medicine of Tsinghua University, it has built new gene knock-in animal disease model platforms such as fruit flies and mice and a central nervous system adeno-associated virus vector (AAV) screening platform, and is committed to developing treatments for neurological diseases such as amyotrophic lateral sclerosis (ALS, commonly known as "Lou Gehrig's disease"), stroke, Parkinson's disease, etc.

Luoqi Biotech Completes B2 Round of Financing of Nearly RMB 200 Million, Led by Qiming Venture Partners

On August 2, Shanghai Luoqi Biotechnology Co., Ltd. (hereinafter referred to as "Luoqi Biotechnology") successfully completed a B2 round of financing of nearly 200 million yuan. This round of financing was led by Qiming Venture Partners, with participation from Huangpu Biotechnology Fund and Jiuyu Investment, and old shareholder Shengdi Investment continued to increase its investment. The company also announced that the B round of financing has been successfully concluded, with a total financing of nearly 300 million yuan.

Founded in 2017, Luoqi Biopharma focuses on the research and development of inhaled nano-antibody drugs. It has established a complete R&D, CMC and pilot production system, built five major innovative technology platforms, and pioneered the research of rapidly effective and highly specific inhaled nano-antibodies. It is currently the only company in China with the full-process development capabilities of inhaled nano-antibodies.

Technology Manufacturing

Juqiao Industrial completed a seed round of financing of nearly 10 million yuan, with Guoxin Xihai Fund participating in the investment

On July 29, it was reported that Juqiao Industrial has completed a seed round of financing of nearly 10 million yuan. The investor is Guosen Xihai Fund, and Inspur Capital serves as the long-term exclusive financial advisor. This round of financing will mainly be used for digital factory construction and production line laying.

Juqiao Industry was established in November 2023, focusing on the research and development of flexible fiber sensor technology. By combining a number of innovative technologies such as fiber pressure sensors, fiber electrodes, and tension sensing fibers with relevant algorithms, it can achieve the perception, conduction, calculation, and control of ECG, pressure, tension and other signals.

Shanhe Analog & Digital completed tens of millions of yuan in Pre-A round of financing, led by Glory Capital and Yongxin Ark

On July 29, SBC chip R&D company "Shanhe Analog" completed tens of millions of RMB in Pre-A round of financing, led by Glory Capital and Yongxin Ark, and followed by Wenzhi Capital. The funds raised will be used for technology R&D and product delivery.

Shanhe Analog & Digital was established in 2023. Its core R&D team has more than 15 years of experience in automotive chip R&D from NXP and Infineon, the world's leading chip companies. It is directly involved in the development of a number of SBCs and hybrid analog and digital chips. The company also plans to establish a R&D center in Europe.

LiblibAI completes RMB 100 million Series A financing led by Mingshi Capital

On July 29, it was reported that the AI ​​image generation platform "LiblibAI Libulibu AI" (abbreviated as "LiblibAI") has completed three rounds of financing in the past year, with a total amount of hundreds of millions of yuan: the angel round investors were Source Code Capital, Gaorong Ventures and GSR Ventures; the second round was led by strategic investors; the third round was led by Vision Fund; and old shareholders continued to support for multiple rounds.

The company was founded in 2023. It is understood that the financing will be used in three aspects: building a large-scale computing power middle platform to support user reasoning and training computing power needs; research and development of image model-based plug-ins, fine-tuning models and control capabilities; support and operation of developer ecology and original model authors.

Guangzhou Junxing Supply Chain completed RMB 30 million Series A financing, led by Fuxing Capital

On July 31, the integrated supply chain platform "Guangzhou Junxing Supply Chain" announced that it had successfully completed a round A financing of up to 30 million yuan. The financing was led by Fuxing Capital. This round of funds will mainly increase investment in technology research and development and innovation to improve the level of supply chain intelligence; secondly, expand marketing and service networks to further consolidate and enhance market position.

The company was established in 2023 and is an enterprise mainly engaged in business services.

INMO Technology completed a nearly 100 million yuan B round of financing, with participation from Hongxin Fund, Chenghua Science and Technology Venture Capital and others

On July 31, smart glasses manufacturer INMO Technology completed a B round of financing of nearly 100 million yuan. This round of financing was jointly participated by Sichuan Development Hongxin Fund, Chenghua Science and Technology Venture Capital Company and Jiangxi Zhonghuan Investment Group.

Shenzhen Yingmu Technology Co., Ltd. was established in 2020. It is a leading domestic smart glasses company and the pioneer and leading brand of wireless AR glasses. It has previously received multiple rounds of strategic investments from well-known investment institutions such as Matrix Partners, Eagle Fund, Zhiwen Group, Jiuhe Venture Capital, and 37 Interactive Entertainment.

Hengdao Technology completed a round B financing of over 50 million yuan, with Yuanjing Capital as the sole investor

On July 31, Zhejiang Hengdao Technology announced that it had completed a round B financing of over 50 million yuan, exclusively invested by Yuanjing Capital. The funds will be mainly used to increase the research and development of hot runner technology, build production capacity, and expand the scale of hot runner business.

Hengdao Technology was founded in 2010. It focuses on the research and development of precision hot runner technology and the production and manufacturing of injection mold hot runner systems. It is a hidden champion enterprise in Zhejiang Province.

DeepBlue Aerospace completes B2 round of financing worth hundreds of millions of yuan, led by Wuxi High-tech Zone Investment and Control Group

On July 31, Jiangsu Deep Blue Aerospace Co., Ltd. (hereinafter referred to as Deep Blue Aerospace) recently completed its B2 round of financing, led by Wuxi High-tech Zone Investment and Control Group, and completed and locked in nearly 1 billion yuan of funds. The financing funds will be mainly used to strengthen technology research and development, expand production scale, optimize supply chain management and accelerate market promotion.

Deep Blue Aerospace is a company that Hard Krypton has been paying attention to for a long time. The company was founded in 2016 and focuses on the research and development of liquid recyclable and reusable launch vehicle technology and products, and provides commercial launch services. Deep Blue Aerospace is the first company in China to achieve a kilometer-level rocket vertical take-off and landing recovery test. Its rocket recovery technology includes rocket recovery control system, deep variable thrust liquid oxygen-kerosene rocket engine, landing leg extension and retraction, grid rudder control, etc., which can achieve soft landing recovery and reuse of rockets. Among them, the Nebula-1 rocket, as the core product of Deep Blue Aerospace, is a medium-sized two-stage liquid oxygen-kerosene reusable rocket.

Lingming Photonics Completes C2 Round of Financing, Zhejiang Financial Holdings Leads the Investment

On July 31, Shenzhen Lingming Photonics Technology Co., Ltd. (referred to as "Lingming Photonics") announced the completion of its C2 round of financing, led by Zhejiang Financial Holdings.

Since its establishment in May 2018, Lingming Photonics' core team has focused on breakthroughs in SPAD (single photon avalanche diode) technology in order to gain a leading position in the field of 3D sensing. This round of financing will provide Lingming Photonics with sufficient financial support to accelerate the development of its high-end 3D camera chips.

SKG completes strategic financing of hundreds of millions of yuan, with Morgan Stanley as the sole investor

On July 31, SKG announced that it had signed a strategic investment cooperation agreement with Morgan Stanley, and obtained an exclusive investment of 100 million yuan from Morgan Stanley's private equity department. SKG said that with the help of Morgan Stanley, SKG's global strategic layout will be further accelerated. So far, SKG's products have been sold in more than 50 countries and regions, with cumulative global sales exceeding 27 million.

Founded in 2007, SKG is a massage appliance company originated from Shunde, Foshan. Starting with the earliest neck massager products, SKG's massage and hot compress products have now covered the eyes, neck, waist, knees and other parts of the body.

Shenglian Technology Completes B++ Round of Financing, Shangxin Capital Participates in the Investment

On August 1, Shanghai Shenglian Technology announced the completion of its B++ round of financing, with Shangqi Capital as the investor. The specific amount of financing was not disclosed, and the funds will be mainly used for the company's high-speed Serdes IP and chip product research and development and mass production.

Founded in 2014, Shenglianke is a semiconductor chip design company established in Silicon Valley, USA. The company focuses on ultra-high-speed SerDes IP and product solutions. Its main products include PAM4 56G/112Gbps SerDes, PCIe5.0/6.0, 16G D2D, IO Die, automotive high-speed 4~24G SerDes and other high-performance IP products.

Xinyuan New Materials completes Series B financing, BYD participates in investment

On August 1, Xinyuan New Materials received exclusive investment from BYD and completed its B round of financing. Shenzhen Xinyuan New Materials Co., Ltd. (hereinafter referred to as "Xinyuan New Materials"), as the first domestic supplier of sintered silver on vehicles, has successfully entered the supply chain of BYD and other leading car companies with its advanced products. It is expected that by the end of 2024, the total number of end-customer installations will exceed 800,000 units.

Xinyuan New Materials Co., Ltd. was established on April 12, 2022 and is located in Bao'an District, Shenzhen. The company focuses on the research and development, production, sales and technical services of thermal interface materials for electronic packaging, providing high heat dissipation and high reliability solutions for power semiconductor packaging and advanced integrated circuit packaging.

Stardust Intelligence Completes Pre-A Round of Financing of Tens of Millions of Dollars, Led by Matrix Partners

On August 1, AI robot company Astribot announced the completion of tens of millions of dollars in Pre-A round of financing, led by Matrix Partners, followed by industrial capital such as Daotong Investment and Qinghui Investment, and old shareholder Yunqi Capital. Huaxing Capital served as the exclusive financial advisor. This round of financing will be used for top talent recruitment, R&D investment, commercial deployment and other work.

Stardust Intelligence was founded in December 2022 and is committed to enabling billions of people to have AI robot assistants and promoting the vision of human-machine coexistence, co-creation, and win-win. The company focuses on developing the "new generation of the most powerful AI robot assistants" that can learn, think, and work like humans, interact with people fluently and intelligently, use human tools and equipment, and help people complete boring, difficult or dangerous tasks. It continuously expands the boundaries of application scenarios, realizes universal operation capabilities in all scenarios, and leads the "AI+Robot" technology innovation.

Boxin Quanyu Cosmos' parent company completes strategic investment of tens of millions of yuan, with Shangwen Investment as the sole investor

On August 2, Luwa Culture Communication (Shanghai) Co., Ltd., the parent company of Boxin Universe, a leading large-space immersive interactive content brand in China, and Shanghai Cultural Industry Development Investment Fund (referred to as "Shanghai Cultural Industry Development Investment Fund") jointly announced that they had reached an investment agreement worth tens of millions of yuan.

Founded in 2018, Boxin Universe is an innovative company dedicated to integrating culture, art and technology through offline immersive virtual reality (VR) technology.